Last update 20 Mar 2025

Autologous cultured urological tissue cells (inRegen)

Overview

Basic Info

Drug Type
Cell therapy
Synonyms
NeoBladder Augment, NeoBladder Replacement
Target-
Action-
Mechanism
Cell replacements
Therapeutic Areas
Nervous System DiseasesUrogenital DiseasesOther Diseases
Active Indication-
Inactive Indication
Chronic Kidney DiseasesUrinary Bladder, NeurogenicUrologic Diseases
Originator Organization
Tengion, Inc.Tengion, Inc.
Active Organization-
Inactive Organization
Tengion, Inc.Tengion, Inc.InRegen
Drug Highest PhaseDiscontinuedPhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with Autologous cultured urological tissue cells (inRegen)
NCT01846715
/ TerminatedPhase 1
A Phase 1, Open-Label Safety and Delivery Optimization Study of an Autologous Neo-Kidney Augment (NKA) in Patients With Chronic Kidney Disease (CKD)
100 Clinical Results associated with Autologous cultured urological tissue cells (inRegen)
Login to view more data
100 Translational Medicine associated with Autologous cultured urological tissue cells (inRegen)
Login to view more data
100 Patents (Medical) associated with Autologous cultured urological tissue cells (inRegen)
Login to view more data
100 Deals associated with Autologous cultured urological tissue cells (inRegen)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Chronic Kidney DiseasesPhase 2
Sweden
Tengion, Inc.Tengion, Inc.
01 Apr 2013
Urinary Bladder, NeurogenicPhase 2
United States
Tengion, Inc.Tengion, Inc.
-
Urologic DiseasesPhase 2
United States
InRegen
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free